We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Spiriva is a long-acting muscarinic antagonist (LAMA) approved for use in chronic obstructive pulmonary disease and is available in a dry-powder inhale and soft mist inhaler (Respimat) device.